Literature DB >> 15719347

Ring-closing metathesis of C-terminal allylglycine residues with an N-terminal beta-vinyl-substituted phosphotyrosyl mimetic as an approach to novel Grb2 SH2 domain-binding macrocycles.

Shinya Oishi1, Zhen-Dan Shi, Karen M Worthy, Lakshman K Bindu, Robert J Fisher, Terrence R Burke.   

Abstract

Ring-closing metathesis (RCM) of peptides often requires insertion of allylglycines at the intended sites of ring juncture, which can result in the displacement of residues that are needed for biological activity. This type of side-chain deletion can be avoided by appending beta-vinyl substituents onto the parent residues at the intended sites of ring juncture, thereby effectively converting them into functionalized allylglycine equivalents. Such an approach has been previously applied in modified form to growth-factor receptor bound 2 (Grb2) SH2 domain-binding peptides by using an N-terminal beta-vinyl-functionalized phosphotyrosyl mimetic and C-terminal 2-allyl-3-aryl-1-propanamides that lacked the alpha-carboxyl portion of allylglycine residues. These C-terminal moieties involved lengthy synthesis and once prepared, required an individual total synthesis of each final macrocycle. Work reported herein significantly enhances the versatility of the original approach through the use of C-terminal allylglycine amides that can be prepared from commercially available L- and D-allylglycines and suitable amines. This methodology could be generally useful where macrocylization is desired with maintenance of functionality at a site of ring juncture.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15719347     DOI: 10.1002/cbic.200400298

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


  7 in total

Review 1.  Targeting kinase signaling pathways with constrained peptide scaffolds.

Authors:  Laura E Hanold; Melody D Fulton; Eileen J Kennedy
Journal:  Pharmacol Ther       Date:  2017-02-07       Impact factor: 12.310

2.  Application of azide-alkyne cycloaddition 'click chemistry' for the synthesis of Grb2 SH2 domain-binding macrocycles.

Authors:  Won Jun Choi; Zhen-Dan Shi; Karen M Worthy; Lakshman Bindu; Rajeshri G Karki; Marc C Nicklaus; Robert J Fisher; Terrence R Burke
Journal:  Bioorg Med Chem Lett       Date:  2006-10-15       Impact factor: 2.823

3.  Structural examination of ring-closing metathesis-derived 15-member macrocycles as Grb2 SH2 domain-binding tetrapeptide mimetics.

Authors:  Fa Liu; Karen M Worthy; Lakshman K Bindu; Robert J Fisher; Terrence R Burke
Journal:  J Org Chem       Date:  2007-11-09       Impact factor: 4.354

4.  Selectivity and mechanism of action of a growth factor receptor-bound protein 2 SRC homology 2 domain binding antagonist.

Authors:  Alessio Giubellino; Zhen-Dan Shi; Lisa M Miller Jenkins; Karen M Worthy; Lakshman K Bindu; Gagani Athauda; Benedetta Peruzzi; Robert J Fisher; Ettore Appella; Terrence R Burke; Donald P Bottaro
Journal:  J Med Chem       Date:  2008-12-11       Impact factor: 7.446

5.  Identification of Shc Src homology 2 domain-binding peptoid-peptide hybrids.

Authors:  Won Jun Choi; Sung-Eun Kim; Andrew G Stephen; Iwona Weidlich; Alessio Giubellino; Fa Liu; Karen M Worthy; Lakshman Bindu; Matthew J Fivash; Marc C Nicklaus; Donald P Bottaro; Robert J Fisher; Terrence R Burke
Journal:  J Med Chem       Date:  2009-03-26       Impact factor: 7.446

Review 6.  Structural and pharmacological effects of ring-closing metathesis in peptides.

Authors:  Øyvind Jacobsen; Jo Klaveness; Pål Rongved
Journal:  Molecules       Date:  2010-09-21       Impact factor: 4.411

7.  Development of Grb2 SH2 Domain Signaling Antagonists: A Potential New Class of Antiproliferative Agents.

Authors:  Terrence R Burke
Journal:  Int J Pept Res Ther       Date:  2006-03-14       Impact factor: 1.931

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.